Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists

BACKGROUND: To compare risk of diabetic retinopathy (DR) between patients taking sodium-glucose cotransporter-2 inhibitors (SGLT2is) and those taking glucagon-like peptide-1 receptor agonists (GLP1-RAs) in routine care. METHODS: This retrospective cohort study emulating a target trial included patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Tzu-Yi, Kang, Eugene Yu-Chuan, Shao, Shih-Chieh, Lai, Edward Chia-Cheng, Garg, Sunir J., Chen, Kuan-Jen, Kang, Je-Ho, Wu, Wei-Chi, Lai, Chi-Chun, Hwang, Yih-Shiou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244193/
https://www.ncbi.nlm.nih.gov/pubmed/36872060
http://dx.doi.org/10.4093/dmj.2022.0221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244193/
https://www.ncbi.nlm.nih.gov/pubmed/36872060
http://dx.doi.org/10.4093/dmj.2022.0221

Ejemplares similares